Osivax Company
Osivax is developing a new class of universal vaccines empowering both arms of the immune system.
.png)
Headquarters:
Lyon, Rhone-Alpes, France
Employee Number:
58
Industry:
Immuno-Virotherapies
Founded Date:
2017
Funding Status:
Private